Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- NEW PRODUCTS
December 18, 2006
- NEW PRODUCTS
December 18, 2006
- REGULATORY NEWS IN BRIEF
December 18, 2006
- GSK to Discontinue Research in Japan
December 11, 2006
- Blopress Remained Top-selling Drug in 3rd Qtr: IMS Japan
December 11, 2006
- Larger Number of Patients per Facility Essential for Spearhead Medical Research: Dr Tanaka
December 11, 2006
- BUSINESS NEWS IN BRIEF
December 11, 2006
- R&D NEWS IN BRIEF
December 11, 2006
- SEMINAR
December 11, 2006
- Kenporen Preparing Pamphlet on Generic Drugs
December 11, 2006
- GENERIC NEWS IN BRIEF
December 11, 2006
- Terumo's Triplex Artificial Blood Vessel Recommended for Approval
December 11, 2006
- Criteria Established for "Observation Services"
December 11, 2006
- PhRMA
December 11, 2006
- NEW PRODUCTS
December 11, 2006
- Survey Reveals Major Gap in New Drug Access in US/EU vs. Japan
December 11, 2006
- MEDICAL DEVICE NEWS IN BRIEF
December 11, 2006
- 4 New Drugs Recommended for Approval by 2nd Committee on Drugs
December 11, 2006
- NEW PRODUCTS
December 11, 2006
- 9 New Drugs Recommended for Approval by 1st Committee on Drugs
December 11, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…